Embryo arrest, where a fertilized egg stops dividing before reaching the blastocyst stage, happens to roughly a third of all embryos in IVF. Even in women under 30, the median blastocyst conversion rate is about 67%, meaning one in three fertilized eggs naturally stalls along the way. While no strategy can guarantee every embryo will keep developing, understanding why arrest happens reveals several practical levers that patients and clinics can pull to improve the odds.
Why Embryos Stop Developing
The single biggest driver of embryo arrest is chromosomal abnormality. A study using genetic testing on arrested embryos found that 94% carried some form of aneuploidy, an incorrect number of chromosomes. These errors can originate from the egg, the sperm, or from faulty cell division in the first few days after fertilization. Some embryos with mild chromosomal irregularities can still reach the blastocyst stage, but severe errors tend to trigger a built-in self-destruct process that halts development entirely.
Arrest can happen at different points for different reasons. Many embryos stall around the 8-cell stage (day 3), which is when the embryo’s own genome switches on and takes over from the maternal machinery that powered the first few divisions. If the genetic instructions are too damaged to run the show, development stops. Other embryos make it past day 3 but fail between the compaction and blastocyst stages (days 4 to 6), often because the embryo lacks the energy reserves to complete this more metabolically demanding transition.
The Role of Egg Quality and Maternal Age
Every egg carries a stockpile of mitochondria, the tiny structures inside cells that generate energy. These mitochondria are the embryo’s only power source for the first several days of life, and research shows that oocytes need a threshold number of mitochondrial DNA copies to sustain viable development. As maternal age increases, mitochondrial function in embryos measurably declines. Specifically, the energy output at the morula stage (day 4) drops with age, leading to lower rates of progression from morula to blastocyst. This is one reason arrest rates climb steadily after age 35, even though more than 40% of fertilized eggs still reach blastocyst in women 44 and older.
Improving mitochondrial function before egg retrieval is one of the few things patients can directly influence. Coenzyme Q10, an antioxidant that supports mitochondrial energy production, has accumulated meaningful clinical evidence. For women with normal ovarian reserve, 200 mg daily for 30 to 35 days before stimulation has been shown to raise CoQ10 levels in follicular fluid and improve oocyte maturation. For women with diminished ovarian reserve, a higher dose of 600 mg daily for 60 days appears more effective at enhancing ovarian response. Women over 35 may benefit from longer-term supplementation of 200 mg daily for at least 90 days to counteract the natural age-related decline in the body’s own CoQ10 production.
How Sperm DNA Damage Contributes
Arrest isn’t only about the egg. High levels of DNA fragmentation in sperm have a direct effect on embryo survival, particularly after the embryonic genome activates around day 3. Before that point, the egg’s own repair mechanisms can compensate for some sperm DNA damage. Once the paternal genome needs to contribute instructions for further development, unrepaired breaks in sperm DNA trigger programmed cell death in the embryo’s cells, leading to arrest.
Studies show that embryos created from sperm with high DNA damage display widespread markers of apoptosis (cellular self-destruction), even when paired with good-quality eggs. The eggs respond correctly to the damage signals, which is actually a sign of healthy cellular quality, but the result is still a stopped embryo. If you’ve experienced repeated embryo arrest, a sperm DNA fragmentation test can help identify whether this is a contributing factor. Lifestyle changes such as reducing heat exposure, quitting smoking, improving diet, and treating infections or varicoceles can lower fragmentation levels over a two-to-three-month window as new sperm are produced.
Lab Conditions That Make a Difference
The environment inside the IVF lab has a surprisingly large influence on whether embryos keep dividing. One of the most well-established factors is oxygen concentration. Inside the human body, the fallopian tube and uterus maintain oxygen levels between 2% and 8%, far lower than the 20% oxygen in room air. European Society of Human Reproduction and Embryology (ESHRE) guidelines now recommend culturing embryos at 2% to 8% oxygen, with 5% being the most common target. Labs that culture embryos at atmospheric oxygen (20%) expose them to oxidative stress that can damage DNA and stall development. If your clinic still uses atmospheric oxygen for extended culture, this is worth asking about.
Temperature stability, pH balance, and osmolality of the culture media all matter too. Every time an incubator door opens, the internal environment shifts, and frequent disruptions can harm developing embryos. This is one reason many high-performing labs now use benchtop incubators with individual chambers, so checking one patient’s embryos doesn’t disturb another’s. ESHRE consensus guidelines emphasize that each lab should minimize the frequency of embryo observations and ensure that culture conditions remain as stable as possible throughout the entire growth period.
Time-Lapse Monitoring
Time-lapse incubators represent a practical solution to the observation dilemma. These systems contain built-in cameras that photograph embryos at regular intervals without removing them from the incubator, maintaining uninterrupted culture while generating a detailed developmental timeline. Research on over 2,000 blastocysts has shown that the timing of key milestones, such as when pronuclei fade, when the embryo reaches 2, 4, and 8 cells, and when blastulation begins, reliably distinguishes high-potential embryos from those likely to arrest or produce lower-quality blastocysts. Embryos that reach the 4-cell stage earlier tend to form blastocysts with better structure, while delayed division timings correlate with poorer outcomes. This information helps embryologists select the most viable embryos for transfer, though it doesn’t prevent arrest itself.
Growth Hormone as an Adjuvant
For women classified as poor responders, meaning they produce few eggs despite stimulation medication, growth hormone has been studied as an add-on treatment. Growth hormone works by amplifying the effect of stimulation drugs on the ovaries, boosting local production of a signaling molecule called IGF-1 that supports follicle development, estrogen production, and oocyte maturation. A Cochrane review of 11 trials involving over 1,000 poor responders found that adding growth hormone increased pregnancy rates from a baseline of about 15% to somewhere between 19% and 31%. It also resulted in an average of about 1.4 more eggs retrieved per cycle. The evidence for live birth improvement exists but is rated as very low certainty, so this remains a decision to weigh carefully with your fertility specialist based on your specific situation.
What Patients Can Actually Control
Much of what determines whether an embryo arrests happens at the molecular level before you ever start a cycle. The most impactful steps are those taken in the two to three months before egg retrieval, since that’s roughly how long it takes for an egg to complete its final maturation journey.
- CoQ10 supplementation: 200 to 600 mg daily depending on ovarian reserve, started at least 30 to 90 days before stimulation.
- Sperm health optimization: A DNA fragmentation test if arrest has been recurrent, followed by targeted lifestyle or medical interventions as needed.
- Clinic selection: Confirming the lab uses reduced oxygen culture (5%), time-lapse or minimal-disturbance incubation, and validated culture media systems.
- General health factors: Maintaining a healthy weight, managing oxidative stress through diet rich in antioxidants, avoiding smoking and excessive alcohol, and getting adequate sleep all support both egg and sperm quality at the cellular level.
It’s also worth noting that some degree of embryo arrest is completely normal biology, not a sign that something went wrong. The human reproductive system is remarkably selective: even under perfect conditions, a significant portion of fertilized eggs carry genetic errors incompatible with further development. The goal isn’t zero arrest. It’s giving every viable embryo the best possible environment to reach its potential.